Bio-Hermes Clinical Trial Launches to Compare Biomarker Tests;

Seeks Rapid, Less Expensive Diagnostics for Alzheimer’s Disease

Lilly, AbbVie, Merck, the Alzheimer’s Drug Discovery Foundation, and leading technology companies join the first platform study assessing various biomarker tests’ ability to predict the presence of Alzheimer’s